๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zhuhai
Clinical trial register · China

Clinical Trials in Zhuhai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University11 Ming-Yuan Chen11 Fifth Affiliated Hospital, Sun Yat-Sen University8 Beijing Normal University5 Nanfang Hospital, Southern Medical University4
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Zhuhai

78 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Efficacy Analysis of Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Therapy in the Treatment of Chronic Subjective Tinnitus
NCT07794462Chronic Subjective Tinnitus
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
444
Guangzhou, Huizhou, Jieyang, Zhongshan, Zhuhai, Shanghai
2026-10-01
Not yet open
Full-wrap Versus Conventional Suspension for Reducing Soft Palate Injury Rate in Transoral Surgery
NCT07552545Adenoid Hypertrophy, Tonsillar Hypertrophy, Nasopharyngeal Diseases, Nasopharyngeal Tumors
Sun Yat-sen University
Not applicable
138
Zhuhai
2026-09-30
Not yet open
Cognitive and Emotional Inoculation Against Nutrition-Related Misinformation in Young Adults
NCT07803380Health Misinformation, Misinformation, Digital Health Literacy, Health Communication
Beijing Normal University
Not applicable
330
Zhuhai
2026-09-01
Not yet open
Metaphor-Based Smoking Cessation Intervention
NCT07803354Smoking Cessation, Mobile Health
Beijing Normal University
Not applicable
200
Zhuhai
2026-09-01
Recruiting
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
NCT07512596Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
48
Bengbu, Beijing, Chongqing, Foshan, Guangzhou, Shenzhen, Zhuhai, Shijiazhuang
2026-07-21
Recruiting
PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract
NCT07700498Primary Open Angle Glaucoma and Cataracts
Nanfang Hospital, Southern Medical University
Not applicable
106
Ningxia, Guangzhou, Luzhou, Zhengzhou, Zhuhai
2026-07-15
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
NCT07419295Bladder Cancer
Merck Sharp & Dohme LLC
Phase 3
590
Beijing, Chongqing, Guangzhou, Zhuhai, Wuhan, Changsha, Nanjing, Nanchang
2026-04-23
Not yet open
Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA)
NCT07484035Cow's Milk Protein Allergy (CMPA)
Heilongjiang Feihe Dairy Co. Ltd.
Not applicable
124
Beijing, Foshan, Zhuhai, Xiangtan, Wuxi, Chengdu
2026-03-05
Recruiting
Becotatug Vedotin (MRG003) in Combination With PD-1 Inhibitor Versus PD-1 Inhibitor for the Treatment of EGFR-positive, CPSโ‰ฅ1 Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07524452Locally Advanced Head and Neck Squamous Cell Carcinoma
Ming-Yuan Chen
Phase 3
430
Zhuhai
2026-02-06
Recruiting
Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases
NCT07481799Oligo-metastatic Cancer
Ming-Yuan Chen
Phase 3
200
Zhuhai
2026-02-06
Recruiting
Prediction Model for MINS After Major Hepatobiliary Surgery
NCT07335042Myocardial Injury After Noncardiac Surgery (MINS), Postoperative Complications, Liver Neoplasm, Hepatobiliary Diseases
Beijing Tsinghua Chang Gung Hospital
Observational
1,800
Beijing, Chongqing, Qingdao, Shandong, Zhuhai
2026-01-14
Recruiting
Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral Liquid
NCT07311772Nasopharyngeal Cancinoma (NPC), Radiation-induced Oral Mucositis
Sun Yat-sen University
Phase 3
386
Beijing, Fuzhou, Guangzhou, Shantou, Zhuhai, Nanning, Wuzhou, Changsha
2025-12-16
Recruiting
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
NCT07328854Nasopharyngeal Carcinoma
Ming-Yuan Chen
Phase 3
346
Hefei, Fuzhou, Guangzhou, Shantou, Zhongshan, Zhuhai, Nanning, Wuzhou
2025-11-20
Recruiting
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
NCT07110415Coronary Heart Disease, Cardiac Dysfunction
SPH Qingdao Growful Pharmacetical Co.,Ltd
Phase 4
2,708
Haozhou, Beijing, Chongqing, Lanzhou, Guangzhou, Shantou, Zhuhai, Guilin
2025-11-06
Active, closed
Intervention to Reduce Sedentary Behavior During School Recess Among Adolescents
NCT07451535Sedentary Behaviour, Physical Activity, Adolescents, School-based Intervention
South China Normal University
Not applicable
1,000
Foshan, Guangzhou, Shenzhen, Zhuhai, Haikou, Jinzhong, Jinzhou
2025-10-08
Recruiting
Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT07581821Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen
Phase 2
33
Zhuhai
2025-09-15
Recruiting
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
NCT07093814Glioblastoma
Guangzhou Virotech Pharmaceutical Co., Ltd.
Phase 1/2
42
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Zhuhai, Nanning, Jinan
2025-09-02
Not yet open
RSV in Acute Respiratory Infection Surveillance Among Community-Dwelling Elderly Aged โ‰ฅ50 Years in China
NCT07075029Acute Respiratory Infections (ARIs)
Huashan Hospital
Observational
28,800
Xiamen, Zhuhai, Zunyi, Xinxiang, Yichang, Nanjing, Jiujiang, Shenyang
2025-09-01
Active, closed
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
NCT07060885Allergic Rhinoconjunctivitis, Allergic Rhinitis
ALK-Abellรณ A/S
Phase 3
327
Beijing, Fuzhou, Guangzhou, Shenzhen, Zhuhai, Nanning, Haikou, Changshacun
2025-09-01
Recruiting
Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents
NCT06570122Smoking Cessation
Beijing Normal University
Not applicable
300
Zhuhai
2025-09-01
Recruiting
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
NCT07170345Hepatocellular Carcinoma (HCC), Microvascular Invasion (MVI)
Chinese Academy of Sciences
Observational
400
Fuzhou, Guangzhou, Zhuhai, Nanning, Guiyang, Zhengzhou, Shenyang, Chengdu
2025-09-01
Active, closed
Mobile-Based Intervention to Promote Physical Activity Among the Elderly
NCT06570083Mobile Health, Physical Activity
Beijing Normal University
Not applicable
200
Zhuhai
2025-09-01
Recruiting
Clinical Multimodal Surveillance of Respiratory Syndrome Pathogens
NCT07694648Respiratory Tract Infections (RTI), Respiratory Syndrome, Acute, Severe, Acute Respiratory Infections (ARIs)
Huashan Hospital
Observational
2,398
Beijing, Guangzhou, Zhuhai, Shijiazhuang, Harbin, Jiamusi, Shangqiu, Zhengzhou
2025-09-01
Not yet open
Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
NCT07172126Metastatic Castration-resistant Prostate Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
291
Chongqing, Zhuhai, Shanghai
2025-09
Recruiting
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
NCT07181499NSCLC, Adjuvant Drug Therapy, EGFR
Betta Pharmaceuticals Co., Ltd.
Phase 2
28
Guangzhou, Zhuhai
2025-09
Recruiting
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
NCT07188584Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen
Phase 3
166
Zhuhai
2025-08-20
Not yet open
A Study to Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests
NCT07087041Decompensated Cirrhosis, Hepatitis B Virus (HBV) Infection, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Alcohol-Related Liver Disease
Beijing Friendship Hospital
Observational
735
Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Zhuhai, Guiyang, Shiyan
2025-07-15
Recruiting
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial
NCT07070479Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen
Phase 2
208
Guangzhou, Zhongshan, Zhuhai, Changsha
2025-06-24
Recruiting
PeRsonalized Blood prEssure Management on Postoperative Complications and Mortality in hIgh-risk Patients Undergoing Major Non-cardiac Surgery
NCT06952387Hypotension
Nanfang Hospital, Southern Medical University
Not applicable
1,624
Guangzhou, Shenzhen, Zhuhai, Xiโ€™an, Hangzhou
2025-06-03
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,440
Beijing, Chongqing, Fuzhou, Guangzhou, Zhuhai, Nanning, Zhengzhou, Wuhan
2025-05-13
Recruiting
Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy
NCT06817265Non-Proliferative Diabetic Retinopathy
Beletalent (Zhuhai) Pharmaceutical Co., Ltd
Phase 3
360
Xuancheng, Beijing, Guangzhou, Shenzhen, Zhuhai, Guiyang, Shijiazhuang, Kaifeng
2025-04-29
Recruiting
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
NCT06848400Gastric Lesion, Gastritis, Upper Gastrointestinal Bleeding (UGIB), Gastric Dysplasia
Nanfang Hospital, Southern Medical University
Not applicable
482
Guangzhou, Shaoguan, Shenzhen, Zhuhai, Wuxi, Ganzhou, Mianyang
2025-03-03
Recruiting
Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas
NCT06870435Nasopharyngeal Carcinoma (NPC), Screening, Epstein Barr Virus
Ming-Yuan Chen
Not applicable
68,649
Zhuhai
2025-01-24
Not yet open
A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis
NCT06767540Atopic Dermatitis
Akeso
Phase 3
198
Wuhu, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Zhuhai
2025-01-23
Active, closed
AI-powered Smoking Cessation Intervention
NCT06570070Smoking Cessation, Mobile Health
Beijing Normal University
Not applicable
420
Zhuhai
2025-01-22
Recruiting
Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL
NCT06760039Diffuse Large B-Cell Lymphoma
Sun Yat-sen University
Phase 1/2
112
Fuzhou, Lanzhou, Guangzhou, Shenzhen, Zhuhai, Guilin, Ganzhou, Nanchang
2025-01-10
Recruiting
Hospital-Based Management of Patients With Chronic Hepatitis B Virus Infection
NCT06966908Chronic Hepatitis B
Third Affiliated Hospital, Sun Yat-Sen University
Observational
16,300
Guangzhou, Zhuhai
2025-01-03
Recruiting
Ophthalmic Multimodal AI-Assisted Medical Decision-Making
NCT06755190Ocular Diseases
The Eye Hospital of Wenzhou Medical University
Observational
5,000,000
Zhuhai, Wenzhou
2024-12-20
Recruiting
Ophthalmic AI-Assisted Medical Decision-Making
NCT06755060Ocular Diseases
The Eye Hospital of Wenzhou Medical University
Not applicable
100,000
Zhuhai, Wenzhou
2024-12-01
Recruiting
"Xijiang Project" Screening Cohort for NPC
NCT06787456Nasopharyngeal Carcinoma (NPC), Screening
Ming-Yuan Chen
Observational
1,000,000
Zhuhai
2024-11-14
Recruiting
Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients๏ผˆRocket Trial๏ผ‰
NCT06647940Diffuse Large B Cell Lymphoma (DLBCL)
Sun Yat-sen University
Phase 2
39
Guangzhou, Lanzhou, Dongguan, Shantou, Shenzhen, Zhaoqing, Zhuhai
2024-11-01
Recruiting
Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC
NCT06657690Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2
56
Zhuhai
2024-11-01
Recruiting
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
NCT06314282Systemic Lupus Erythematosus (SLE)
AstraZeneca
Observational
200
Guangzhou, Hong Kong, Shenzhen, Zhongshan, Zhuhai
2024-10-22
Recruiting
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
NCT06451861Acute Myeloid Leukemia
Guangdong Provincial People's Hospital
Phase 2
240
Dongguan, Foshan, Guangzhou, Shenzhen, Zhanjiang, Zhuhai, Haikou
2024-08-21
Recruiting
Under Whole-course of Immunotherapy, Gradient Fractionated RT with CCT Versus CFRT with CCT for LANPC Who Achieved PR Post Induction Chemotherapy.
NCT06675214Nasopharyngeal Carcinoma, De-escalation Therapy
Sun Yat-sen University
Phase 3
586
Zhuhai
2024-07-30
Recruiting
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
NCT06472713Recurrent or Metastatic Nasopharyngeal Carcinoma
Ming-Yuan Chen
Phase 2
32
Zhuhai
2024-07-20
Recruiting
A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
NCT06413953Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
140
Guangzhou, Zhuhai, Chengde, Harbin, Changsha, Changzhou, Binzhou, Shanghai
2024-06-27
Recruiting
Single-operator Versus Two-operator Technique in Single-balloon Enteroscopy
NCT06280469Single-balloon Enteroscopy, Operation
Shuhui Liang
Not applicable
228
Lanzhou, Zhuhai, Xi'an
2024-05-01
Active, closed
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
NCT06372496Asthma
GlaxoSmithKline
Phase 4
1,366
Chancheng District, Liwan District, North Street, Nanshan District, Zhuhai
2024-04-16
Recruiting
A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis
NCT06308328Radiation-induced Oropharyngeal Mucositis, Swallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University
Observational
718
Guangzhou, Shaoguan, Shenzhen, Zhuhai, Shanghai, Chengdu
2024-04-01
Recruiting
Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma.
NCT06533267Nasopharyngeal Carcinoma, Intensity Modulated Radiotherapy, Surgery
Sun Yat-sen University
Not applicable
442
Zhuhai
2024-03-25
Recruiting
Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
NCT06060782Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 1
28
Zhuhai
2024-03-06
Not yet open
Effects of CBT-Based Intervention Among Patients With Liver Cancer
NCT05942560Depression, Anxiety, Liver Cancer, CBT
The Nethersole School of Nursing
Not applicable
160
Zhuhai
2023-12-30
Recruiting
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
NCT06220552Recurrent Glioblastoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2
20
Zhuhai
2023-12-27
Recruiting
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
NCT06007729Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company
Phase 2
170
Hefei, Beijing, Fuzhou, Guangzhou, Zhuhai, Nanning, Harbin, Zhengzhou
2023-12-18
Recruiting
Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma
NCT06688760Nasopharyngeal Carcinoma, Surgery, Radiotherapy
Ming-Yuan Chen
Not applicable
86
Guangzhou, Zhuhai
2023-11-01
Recruiting
Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging
NCT06060769Cirrhosis๏ผ› Tumor
Fifth Affiliated Hospital, Sun Yat-Sen University
Observational
1,200
Zhuhai
2023-09-01
Recruiting
Treatment Recommendations for Gastrointestinal Cancers Via Large Language Models
NCT06002425Gastrointestinal Neoplasm Malignant
Chinese Academy of Sciences
Not applicable
400
Jiangmen, Zhuhai, Hohhot
2023-08-29
Recruiting
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
NCT05582174Upper GI Bleeding, Proton Pump Inhibitors
Chinese University of Hong Kong
Phase 4
594
Guangzhou, Shenzhen, Yangjiang, Zhuhai, Hong Kong
2023-05-18
Recruiting
The Efficacy and Safety of De-escalated Postoperative Radiotherapy in Locally Advanced HNSCC With pCR/MPR
NCT05854823Head and Neck Squamous Cell Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Not applicable
23
Zhuhai
2023-04-10
Active, closed
Application of Multitask Deep Learning Model in Grading the Severity of Spinal Facet Joint Degeneration
NCT05635006Facet Joints; Degeneration ; Deep Learning ;Artificial Intelligence
Hai Lv
Observational
1,132
Zhuhai
2022-12-31
Active, closed
A Study Assessing Repathaยฎ in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
NCT06295679Major Cardiovascular Event, Established Atherosclerotic Cardiovascular Disease
Amgen
Observational
7,000
Beijing, Chongqing, Dongguan, Foshan, Guangzhou, Huizhou, Zhuhai, Guilin
2022-12-19
Recruiting
Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
NCT06529562Nasopharyngeal Carcinoma
Ming-Yuan Chen
Not applicable
384
Zhuhai
2022-11-01
Recruiting
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
NCT05523245Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
1,700
Guangzhou, Zhuhai
2022-06-24
Recruiting
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal Carcinoma
NCT05290194Radiotherapy, PD-1 Inhibitor, Capecitabine, Nasopharyngeal Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2
28
Zhuhai
2022-03-28
Active, closed
The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC
NCT05343325Head and Neck Squamous Cell Carcinoma, Neoadjuvant Treatment
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2
25
Zhuhai, Dongguan
2022-03-09
Recruiting
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
NCT05188885Chronic Kidney Disease
Guangdong Provincial People's Hospital
Observational
90,000
Foshan, Guangzhou, Meizhou, Qingyuan, Zhuhai, Ganzhou
2021-12-27
Recruiting
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
NCT05024214Solid Tumors, Non-small Cell Lung Cancer, Renal Cell Carcinoma, Hepatocellular Carcinoma
3D Medicines (Sichuan) Co., Ltd.
Phase 1/2
170
Bengbu, Beijing, Fuzhou, Xiamen, Dongguan, Guangzhou, Zhuhai, Haerbin
2021-11-15
Not yet open
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy
NCT05105945Esophageal Cancer
Fifth Affiliated Hospital, Sun Yat-Sen University
Not applicable
1,164
Zhuhai
2021-11-11
Recruiting
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
NCT05047510Hepatocellular Carcinoma
Chinese Academy of Sciences
Not applicable
60
Zhuhai, Luzhou
2021-09-10
Active, closed
Newly Diagnosed Glioblastoma
NCT04959500Glioblastoma
Sun Yat-sen University
Phase 2
150
Bengbu, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Shenzhen, Zhuhai
2021-07-21
Active, closed
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
NCT05058040Alzheimer Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Phase 4
2,500
Hefei, Beijing, Chongqing, Xianmencun, Dongguan, Guangzhou, Shenzhen, Zhuhai
2021-06-02
Active, closed
Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC
NCT04947241Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 1
20
Zhuhai
2020-12-15
Recruiting
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
NCT04685226Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2
310
Hefei, Beijing, Guangzhou, Zhuhai, Guangdong, Shijiazhuang, Harbin, Luoyang
2020-09-27
Recruiting
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
NCT04453826Nasopharyngeal Cancer, Chemotherapy, Radiotherapy, PD-1 Therapy
Sun Yat-sen University
Phase 3
388
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-09-01
Recruiting
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
NCT04453813Nasopharyngeal Carcinoma, Chemotherapy, Radiotherapy, PD-1 Treatment
Sun Yat-sen University
Phase 3
226
Guangzhou, Shaoguan, Zhongshan, Zhuhai, Wuzhou
2020-07-03
Recruiting
Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma
NCT04425265Surgery, Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Not applicable
500
Guangzhou, Zhuhai, Nanchang
2020-06-30
Recruiting
Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast Cancer
NCT04263298Metastatic Breast Cancer
Herui Yao
Phase 3
210
Guangzhou, Shantou, Shenzhen, Zhangjiang, Zhuhai, Nanning, Changsha
2018-05-01
Rows per page Showing 1–78 of 78
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/zhuhai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 78 of those studies with a site in Zhuhai.

How many clinical trials are recruiting in Zhuhai?

56 of the 78 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 11 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zhuhai), 78 studies
PhaseStudiesRecruitingShare
Not applicable241430.8%
Observational151119.2%
Phase 3141217.9%
Phase 2131116.7%
Phase 1/2546.4%
Phase 4425.1%
Phase 1323.8%

Most active sponsors

Lead sponsors with the most studies (Zhuhai)
Lead sponsorStudiesRecruiting
Ming-Yuan Chen1111
Sun Yat-sen University119
Fifth Affiliated Hospital, Sun Yat-Sen University85
Beijing Normal University51
Nanfang Hospital, Southern Medical University44
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.32
Chinese Academy of Sciences33
Guangdong Provincial People's Hospital22
Huashan Hospital21
Merck Sharp & Dohme LLC22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.